Although preoperative CEA may not be an independent prognosis factor for patients with stage II–III diseases (33, 34), it has predictive value in advanced/metastatic colon cancer (35) and can be combined with other markers or examination methods to evaluate the prognosis of early colon cancer (36). The gene discussed is CEACAM5; the disease is malignant colon neoplasm.